Feasibility study of stereotactic body radiotherapy for metastatic vertebral body tumor

Phase 2

Recruiting

• Conditions: metastatic vertebral body tumor

• Registration Number: JPRN-UMIN000013428
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-03-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient who cannot get MRI 2) Patient who has uncontrolled collagen disease, cardiac disease, respiratory disease or liver disorders. 3) Patient who has progressive neural symptom 4) Lesion which has cord compression grade 2 or 3. 5) Lesion which has vertebral compression fracture. 6) Patient who had chemotherapy with in 1 week before SBRT.

Study & Design

• Study Type: Interventional
• Study Design: Not specified